Enveric Biosciences Inc vs Western Digital Corp — how do they compare? Enveric Biosciences Inc trades at $1.36 (market cap $5.32M), while Western Digital Corp trades at $473.15 (market cap $177.11B). The key difference: Western Digital Corp is far larger — about 33291.4× Enveric Biosciences Inc's market cap, and Western Digital Corp pays a 0.12% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | WDC | |
|---|---|---|
Market Cap | $5.32M | $177.11B |
Sector | Health | Technology |
52-Week High | $17.40 | $746.23 |
52-Week Low | $1.28 | $66.53 |
Enterprise Value | $408.82K | $175.46B |
Dividend Yield | — | 0.12% |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
Western Digital (WDC) trades at $563.32, up 1.4% over 24 hours, with strong recent earnings beats and a bullish analyst consensus. The stock shows neutral technical signals but benefits from robust profitability metrics, including a 55.07% net income margin and 37.73% ROE. Recent news highlights volatility in memory stocks, but AI-driven storage demand and HAMR technology advancements provide growth catalysts.
Outlook remains positive with a $619.07 consensus price target, though risks include competitive pressures from new market entrants and sector volatility. Earnings growth and margin expansion are key drivers, but investors should monitor execution against rising debt levels and industry cyclicality.
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →